Senti Biosciences Holdings Inc (SNTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,808 | -55,319 | -44,415 | -33,009 | -1 |
| Depreciation Amortization | 1,010 | 3,010 | 1,976 | 1,104 | N/A |
| Accounts receivable | 53 | -395 | -345 | -345 | N/A |
| Accounts payable and accrued liabilities | -164 | -617 | 1,716 | 910 | 1 |
| Other Working Capital | 66 | 615 | 3,464 | 2,370 | 1 |
| Other Operating Activity | 784 | 18,071 | 14,940 | 15,111 | -1 |
| Operating Cash Flow | $-10,059 | $-34,635 | $-22,664 | $-13,859 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,380 | -5,543 | -1,558 | -626 | N/A |
| Investing Cash Flow | $-7,380 | $-5,543 | $-1,558 | $-626 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 140 | 1,500 | 1,460 | 1,453 | N/A |
| Other Financing Activity | -595 | 66,935 | 66,952 | 66,472 | 0 |
| Financing Cash Flow | $-455 | $68,435 | $68,412 | $67,925 | $N/A |
| Beginning Cash Position | 59,291 | 31,034 | 31,034 | 31,034 | N/A |
| End Cash Position | 41,397 | 59,291 | 75,224 | 84,474 | N/A |
| Net Cash Flow | $-17,894 | $28,257 | $44,190 | $53,440 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,059 | -34,635 | -22,664 | -13,859 | N/A |
| Capital Expenditure | -7,380 | -5,543 | -1,558 | -626 | N/A |
| Free Cash Flow | -17,439 | -40,178 | -24,222 | -14,485 | 0 |